We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
+9.99%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$474M
AUM Growth
+$37.4M
Cap. Flow
+$752K
Cap. Flow %
0.16%
Top 10 Hldgs %
36.15%
Holding
184
New
5
Increased
50
Reduced
66
Closed
3

Top Buys

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$966K
2
BA icon
Boeing
BA
+$806K
3
UPS icon
United Parcel Service
UPS
+$389K
4
TGT icon
Target
TGT
+$314K
5
PFE icon
Pfizer
PFE
+$269K

Top Sells

Rank Stock Value
1
LEG icon
Leggett & Platt
LEG
+$1.09M
2
LLY icon
Eli Lilly
LLY
+$652K
3
GNTX icon
Gentex
GNTX
+$408K
4
MMS icon
Maximus
MMS
+$321K
5
SMG icon
ScottsMiracle-Gro
SMG
+$257K

Sector Composition

Rank Sector Weight
1 Technology 22.5%
2 Financials 15.47%
3 Healthcare 13.82%
4 Industrials 11.81%
5 Consumer Discretionary 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DTE icon
151
DTE Energy
DTE
$29.5B
$135K 0.03%
1,206
– –
DGRO icon
152
iShares Core Dividend Growth ETF
DGRO
$43.4B
$132K 0.03%
2,280
– –
MLI icon
153
Mueller Industries
MLI
$15.1B
$132K 0.03%
+4,900
New +$121K
MA icon
154
Mastercard
MA
$500B
$130K 0.03%
270
– –
MFC icon
155
Manulife Financial
MFC
$74.4B
$127K 0.03%
5,063
– –
DFAC icon
156
Dimensional US Core Equity 2 ETF
DFAC
$49.3B
$124K 0.03%
3,879
– –
JWN
157
DELISTED
Nordstrom
JWN
$124K 0.03%
6,100
-350
-5% -$6.62K
AVNT icon
158
Avient
AVNT
$3.5B
$123K 0.03%
2,845
– –
VOO icon
159
Vanguard S&P 500 ETF
VOO
$1.01T
$123K 0.03%
256
-12
-4% -$5.49K
MLM icon
160
Martin Marietta Materials
MLM
$33.4B
$123K 0.03%
+200
New +$109K
NOBL icon
161
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$121K 0.03%
2,396
– –
UNH icon
162
UnitedHealth
UNH
$370B
$121K 0.03%
245
– –
GEHC icon
163
GE HealthCare
GEHC
$31.7B
$118K 0.02%
1,295
– –
MED icon
164
Medifast
MED
$145M
$114K 0.02%
2,976
-3,733
-56% -$181K
CSCO icon
165
Cisco
CSCO
$480B
$114K 0.02%
+2,279
New +$114K
ROP icon
166
Roper Technologies
ROP
$38.8B
$113K 0.02%
202
– –
REGN icon
167
Regeneron Pharmaceuticals
REGN
$78.3B
$112K 0.02%
116
– –
CLX icon
168
Clorox
CLX
$12.7B
$110K 0.02%
716
– –
PPG icon
169
PPG Industries
PPG
$26.2B
$109K 0.02%
750
– –
CCEL icon
170
Cryo-Cell International
CCEL
$28.7M
$108K 0.02%
+14,433
New +$81.5K
RY icon
171
Royal Bank of Canada
RY
$290B
$105K 0.02%
1,042
– –
BIIB icon
172
Biogen
BIIB
$30.8B
$103K 0.02%
479
-65
-12% -$15.2K
SWK icon
173
Stanley Black & Decker
SWK
$15.5B
$101K 0.02%
1,035
– –
FISV
174
Fiserv Inc
FISV
$29.7B
– –
-834
Closed -$111K
LEG icon
175
Leggett & Platt
LEG
$1.43B
– –
-41,670
Closed -$1.09M
4 5 6
7
8

Similar funds

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
LWP
LMG Wealth Partners Shreveport, Louisiana $549M AUM 24.44% 1-Year Est. Return
WCP
Wick Capital Partners Wayne, Pennsylvania $548M AUM 16.95% 1-Year Est. Return
BCM
Bienville Capital Management New York $550M AUM 3.49% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $547M AUM 20.34% 1-Year Est. Return
V
VeraBank Henderson, Texas $546M AUM 18.74% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return

Rowlandmiller & Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Rowlandmiller & Partners held 184 positions worth $474M, up 8.6% from $436M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 4.3%. Rowlandmiller & Partners opened 5 new positions and exited 3, leaving the 184-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • Rowlandmiller & Partners's largest Q1 2024 buy was CF Industries: 2,575 shares worth $214K.
  • Rowlandmiller & Partners added most to Vertiv in Q1 2024, an estimated $966K increase.
  • Rowlandmiller & Partners's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $652K.
  • Rowlandmiller & Partners fully exited Leggett & Platt in Q1 2024, selling an estimated $1.09M.
  • Rowlandmiller & Partners's ten largest holdings make up 36% of its $474M portfolio in Q1 2024.
  • Rowlandmiller & Partners opened 5 new positions and closed 3 in Q1 2024.
  • Rowlandmiller & Partners's portfolio value rose 8.6% quarter-over-quarter to $474M.

Based on Rowlandmiller & Partners's 13F filing for Q1 2024, filed 8 Apr 2024.